Clinical trial
Rollover Study Of Lapatinib In Cancer Patients
NCT00169533
Study timeline
Study start (actual)2004-08-19Date precision: day
Registry last updated2017-11-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasms, Breastunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States1San AntonioTexas, United States1NashvilleTennessee, United States1ClevelandOhio, United States1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1DetroitMichigan, United States1Chapel HillNorth Carolina, United States1AlbuquerqueNew Mexico, United States1EdmontonAlberta, Canada1Tel AvivIsrael1LebanonNew Hampshire, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00169533 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.